Skip to main content
Premium Trial:

Request an Annual Quote

Barbara Alving to Leave NCRR

Barbara Alving, the director of the National Center for Research Resources at NIH, is resigning from her post effective at the end of September. Alving became acting director of the center in March 2005 and has been director since April 2007. Alving tells ScienceInsider that she is leaving because she has attained her "major goals," including the creation of the Clinical and Translational Science Awards. As of the first of October, the NCRR programs are supposed to be redistributed to other NIH institutes and centers to make way for the National Center for Advancing Translational Sciences. However, ScienceInsider points out that Congress isn't expected to have a 2012 budget ready by then, and a continuing resolution would have to specifically dismantle NCRR and establish NCATS. "I actually think that NCRR is going to continue on for an indefinite period of time," Alving says.

"To date, no one in the legislative branch has been publicly enthusiastic about Collins' proposed changes, which remain in limbo under a cloud of voiced concerns. Stay tuned," adds Writedit at Medical Writing, Editing & Grantsmanship.

NCRR Deputy Director Louise Ramm will be acting director of NCRR upon Alving's departure.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.